Related Experiment Video

Updated: Apr 17, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
07:56

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts

Published on: January 29, 2018

18.6K

Small for gestational age: growth and puberty issues

Sangita Yadav1, D Rustogi

  • 1Department of Pediatrics, Maulana Azad Medical College and Associated Lok Nayak Hospital,New Delhi, India. Correspondence to: Dr Sangeeta Yadav, Director Professor, Department of Pediatrics, Maulana Azad Medical College (MAMC), Bahadur Shah Zafar Marg, New Delhi 110 002, India. sangeetayadava@gmail.com.

Indian Pediatrics
|February 19, 2015
PubMed

Insights

Infants born small for gestational age (SGA) face increased risks for growth failure, metabolic syndrome, and pubertal issues. Early detection and consistent follow-up in specialized clinics are crucial for managing these long-term health concerns.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Neonatology

Background:

  • Infants born small for gestational age (SGA) exhibit a significantly higher risk of growth failure and adult-onset disorders.
  • Rapid catch-up growth in SGA infants is linked to metabolic syndrome, while inadequate growth may result in short stature.
  • Altered pubertal development is a common concern for children born SGA.

Purpose of the Study:

  • Address the limited literature and lack of established guidelines for managing children born small for gestational age.
  • Provide a structured approach to the follow-up and management of SGA infants.
  • Highlight the importance of early detection and intervention for SGA-related complications.

Main Methods:

  • Conducted a comprehensive literature search on PubMed focusing on SGA epidemiology, growth, puberty, comorbidities, pathogenesis, and management.
  • Emphasized relevance for developing countries in the literature review.
  • Developed a follow-up algorithm for SGA children based on empirical data.

Main Results:

  • Being born small for gestational age predisposes individuals to numerous metabolic and pubertal disorders.
  • Early surveillance in growth clinics is essential for identifying potential issues.
  • Regular follow-up is necessary to prevent and manage associated comorbidities.

Conclusions:

  • Children born small for gestational age require specialized attention due to increased risks of metabolic and pubertal disorders.
  • Early detection and management through growth clinic surveillance are critical.
  • Consistent follow-up plays a vital role in preventing long-term health complications in SGA individuals.
Abstract

More Related Videos

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

28.8K
Assessment of Child Anthropometry in a Large Epidemiologic Study09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

28.1K

Related Concept Videos

Signs of Puberty01:27

Signs of Puberty

Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
2.1K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
23.1K
Anorexia Nervosa01:28

Anorexia Nervosa

Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
2.1K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
863
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
507
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.0K